PHÂN TÍCH THỰC TRẠNG TRIỂN KHAI HOẠT ĐỘNG GIÁM SÁT PHẢN ỨNG CÓ HẠI CỦA THUỐC (ADR) TẠI CÁC CƠ SỞ KHÁM, CHỮA BỆNH Ở VIỆT NAM NĂM 2021

SUMMARY
Adverse drug reactions (ADRs) monitoring programs encourage surveillance, facilitate documentation, promote reporting, provide mechanisms for monitoring the safety of drug use, and stimulate the education of healthcare professionals. To investigate the current ADRs monitoring in healthcare facilities in Vietnam, a nation-wide survey was conducted from September 2021 to November 2021 via a web-based tool supported by the Medical Services Administration (Ministry of Health). Out of 649 eligible responses, spontaneous ADRs reporting was implemented in 91.4% healthcare facilities, and causality assesssment was performed in 52.2%. However, implementation of methods for ADR detection such as targeted spontaneous reporting, adverse drug event trigger tools, active surveillance, patient chart review and interventions by pharmacists has been limited. Among 5 healthcare facility ranks, there was a significant variation in the level of ADRs monitoring implementation (p < 0.001). Regarding to risk management, the most common activity in healthcare facilities was educational programs (68.6%), while hospital meetings (82.7%) and healthcare letters (72.0%) were used the most for risk communication. The lack of human resources (75.5%) was the biggest challenge in implementing ADRs monitoring. In conclusion, ADRs monitoring activities have been initiated in most of the surveyed healthcare facilities and more implemented in higher-rank settings. These results suggested the need for Pharmacovigilance regulatory and professional guideline updates and implementation in healthcare facilities.
Keywords: Adverse drug reactions, healthcare facilities, pharmacovigilance, 2021.

Đầu trang

Tải